Average Co-Inventor Count = 8.05
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genmab A+s (5 from 107 patents)
2. Genmab Holding B.v. (5 from 5 patents)
3. Genmab B.v. (2 from 9 patents)
12 patents:
1. 12448459 - Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof
2. 12275797 - Anti-CD37 antibodies and anti-CD20 antibodies, compositions and methods of use thereof
3. 12247080 - Anti-DR5 antibodies and methods of use thereof
4. 11512137 - Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof
5. 11396553 - Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof
6. 11034772 - Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof
7. 10882913 - Anti-DR5 antibodies and methods of use thereof
8. 10765743 - Antibodies binding AXL
9. 10544220 - Bispecific antibodies against CD3 and CD20
10. 10512688 - Antibodies binding AXL
11. 10500276 - Antibodies binding AXL
12. 10201607 - Antibodies binding AXL